Literature DB >> 32943343

Prolonged operating time is a significant perioperative risk factor for arterial pseudoaneurysm formation and patient death following hemorrhage after pancreaticoduodenectomy.

Jackson Chipaila1, Hiroyuki Kato2, Yusuke Iizawa1, Nagata Motonori3, Daisuke Noguchi1, Kazuyuki Gyoten1, Aoi Hayasaki1, Takehiro Fujii1, Akihiro Tanemura1, Yasuhiro Murata1, Naohisa Kuriyama1, Masashi Kishiwada1, Masanobu Usui1, Hiroyuki Sakurai1, Shuji Isaji1, Shugo Mizuno1.   

Abstract

BACKGROUND: Arterial pseudoaneurysm is a rare but potentially fatal complication after pancreaticoduodenectomy (PD). This study aimed to evaluate the incidence and predictors associated with pseudoaneurysm formation and patient death caused by its rupture. PATIENTS AND
METHOD: We retrospectively reviewed the data of 453 patients who underwent PD from April 2007 to February 2019. Uni- and multivariate analysis and receiver operating characteristic (ROC) curve analysis were performed to identify risk factors and optimal cutoff values.
RESULTS: Among the 453 patients, 22 (4.9%) developed pseudoaneurysm after PD. Median duration from surgery to detection of pseudoaneurysm was 17.0 (1-51) days. The locations of pseudoaneurysms were hepatic artery in 8, splenic artery in 3, gastroduodenal artery in 4, gastric artery in 2 and others in 5 patients, and 72.7% (16/22) of patients presented with hemorrhage. All pseudoaneurysms were treated using angioembolization. Lower age (<65.5 years, p = 0.004), prolonged operation time (Cutoff ˃610 min, p = 0.026) and postoperative pancreatic fistula (POPF) (p = 0.013) were the independent risk factors for development of pseudoaneurysm. 6 (27.3%) patients died due to rupture of pseudoaneurysm and prolonged operation time (Cutoff ˃657 min, p = 0.043) was a significant risk factor for death related to pseudoaneurysm.
CONCLUSION: Prolonged operating time was identified as a risk factor for both pseudoaneurysm formation and patient death following pseudoaneurysm bleeding. Interventional radiology treatment offered a central role in the treatment of pseudoaneurysms after PD. Therefore, it is important to have a high index of suspicion in high risk patients of the possibility of pseudoaneurysm formation and bleeding.
Copyright © 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hemorrhage and Pancreaticoduodenectomy; Operating time; Post-operative pancreatic fistula; Pseudoaneurysm

Year:  2020        PMID: 32943343     DOI: 10.1016/j.pan.2020.08.021

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  4 in total

1.  Natural history of asymptomatic renal artery pseudoaneurysm after robot-assisted partial nephrectomy.

Authors:  Tatsuya Takayama; Akifumi Fujita; Toru Sugihara; Akira Fujisaki; Masahiro Yamazaki; Tomohiro Kameda; Jun Kamei; Satoshi Ando; Shinsuke Kurokawa; Tetsuya Fujimura
Journal:  Transl Androl Urol       Date:  2021-09

2.  The usefulness of preoperative exocrine function evaluated by the 13C-trioctanoin breath test as a significant physiological predictor of pancreatic fistula after pancreaticoduodenectomy.

Authors:  Hiroyuki Kato; Yukio Asano; Masahiro Ito; Norihiko Kawabe; Satoshi Arakawa; Masahiro Shimura; Daisuke Koike; Chihiro Hayashi; Kenshiro Kamio; Toki Kawai; Takayuki Ochi; Hironobu Yasuoka; Takahiko Higashiguchi; Daisuke Tochii; Yuka Kondo; Hidetoshi Nagata; Toshiaki Utsumi; Akihiko Horiguchi
Journal:  BMC Surg       Date:  2022-02-11       Impact factor: 2.102

3.  A Single-Center Retrospective Study of Selected Clinical Parameters and Intraoperative Fluid Management of Patients Undergoing Pancreatoduodenectomy.

Authors:  Patryk Zemła; Justyna Bajak; Bartosz Molasy; Łukasz Krzych; Sławomir Mrowiec; Katarzyna Kuśnierz
Journal:  Med Sci Monit       Date:  2022-04-15

Review 4.  Pancreaticojejunostomy Conducive to Biological Healing in Minimally Invasive Pancreaticoduodenectomy.

Authors:  Ying-Wen Gai; Huai-Tao Wang; Xiao-Dong Tan
Journal:  J Gastrointest Surg       Date:  2022-05-11       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.